Evelyn Partners Group Ltd’s Colgate-Palmolive CL Stock Holding History

Evelyn Partners Group Ltd’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.18M	Buy	+45,589	New	+$3.99M	0.01%	114

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Evelyn Partners Group Ltd's CL Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Colgate-Palmolive (CL) in Q2 2026: 45,589 shares worth $4.18M. The stake represents 0.01% of the portfolio and ranks #114 among its holdings.

1,245 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Evelyn Partners Group Ltd held 45,589 shares of Colgate-Palmolive worth $4.18M as of Q2 2026.
Colgate-Palmolive was a new Evelyn Partners Group Ltd position in Q2 2026.
Colgate-Palmolive made up 0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #114 holding.
1,245 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.